LivaNova (LIVN) Asset Utilization Ratio (2016 - 2026)

LivaNova (LIVN) posted Asset Utilization Ratio of 0.56 for Q1 2026, up 4.1% sequentially from 0.54 in Q4 2025, and up 11.14% YoY from 0.5 in Q1 2025.

LivaNova (LIVN) Asset Utilization Ratio (2016 - 2026) Analysis & Trends

LivaNova has reported Asset Utilization Ratio for 11 years, with the latest figure at 0.56 in Q1 2026.

Quarterly Asset Utilization Ratio rose 11.14% year-over-year to 0.56 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.56 (up 11.14% YoY) and the FY2025 annual result came in at 0.54, up 6.92% from the prior year.
Asset Utilization Ratio grew to 0.56 in Q1 2026 per LIVN's latest filing, from 0.54 in the prior quarter.
Over five years, Asset Utilization Ratio peaked at 0.74 in Q3 2024 and troughed at 0.43 in Q2 2022.
A 5-year average of 0.52 and a median of 0.48 in 2023 frame the typical range for Asset Utilization Ratio.
The sharpest annual moves came in 2024 and 2025: Asset Utilization Ratio jumped 55.99% in 2024, then dropped 29.18% in 2025.
Over 5 years, Asset Utilization Ratio stood at 0.45 in 2022, then rose by 6.93% to 0.48 in 2023, then rose by 2.84% to 0.5 in 2024, then advanced by 7.84% to 0.54 in 2025, then rose by 4.1% to 0.56 in 2026.
According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.56, 0.54, and 0.53 for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Asset Util. (Qtr)
1	Abbott Laboratories	200.11 Bn	194.51 Bn	7.27 Bn	0.42
2	Stryker	129.85 Bn	126.37 Bn	4.50 Bn	0.55
3	Medtronic	119.93 Bn	110.71 Bn	6.41 Bn	0.39
4	Boston Scientific	74.18 Bn	73.64 Bn	3.85 Bn	0.47
5	Edwards Lifesciences	52.54 Bn	48.29 Bn	1.35 Bn	0.48
6	Dexcom	34.76 Bn	32.81 Bn	830.00 Mn	0.76
7	GE HealthCare Technologies	34.25 Bn	32.14 Bn	2.18 Bn	0.57
8	Koninklijke Philips	26.45 Bn	23.13 Bn	4.55 Bn	0.80
9	Steris	23.29 Bn	22.80 Bn	684.20 Mn	0.56
10	LivaNova	4.33 Bn	3.81 Bn	273.67 Mn	0.57

Download Data